Diagnosis of Pediatric Pulmonary Tuberculosis

The diagnosis of pulmonary tuberculosis in children presents unique challenges owing to the often paucibacillary nature of disease, the difficulty in obtaining respiratory specimens, and the overlap of clinical features with other paediatric respiratory conditions. Traditional microbiological approaches, including smear microscopy and culture, frequently yield low sensitivity in this age group. Molecular assays based on nucleic acid amplification have transformed the diagnostic landscape by offering rapid detection and drug-resistance profiling, yet their performance can be hampered by specimen quality and volume. Non-invasive alternatives such as stool or urine testing are under active evaluation, and point-of-care antigen assays have shown promise in HIV-infected children, though with variable accuracy. Radiological assessment, particularly chest radiography, remains an important adjunct, while clinical scoring systems and prediction algorithms are increasingly used to guide treatment decisions in resource-limited settings. Recent efforts have focused on optimising sampling strategies, validating pragmatic diagnostic algorithms for primary care, and applying machine-learning tools to predict microbiological confirmation. These advances aim to improve case detection, reduce diagnostic delays, and support earlier initiation of therapy, thereby addressing the global burden of childhood tuberculosis and contributing to morbidity and mortality reduction.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Diagnosis of Pediatric Pulmonary Tuberculosis publication trend

The graph below shows the total number of articles in diagnosis of pediatric pulmonary tuberculosis across all publications each year (not limited to Nature Index journals).

Technical terms

Paucibacillary disease: A form of tuberculosis characterised by low numbers of bacteria in clinical specimens, leading to reduced sensitivity of direct microbiological tests.

Xpert MTB/RIF Ultra: A rapid, cartridge-based nucleic acid amplification test that detects Mycobacterium tuberculosis complex DNA and rifampicin resistance mutations.

Induced sputum: A technique in which inhalation of hypertonic saline prompts the production of lower respiratory tract secretions for diagnostic sampling.

Composite reference standard: A diagnostic benchmark combining microbiological, clinical and radiological criteria to categorise tuberculosis status in the absence of a single gold-standard test.

Multivariable prediction model: A statistical tool that integrates multiple clinical or radiological parameters to estimate the probability of disease or diagnostic outcome.

References

1. Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: a secondary analysis of the RaPaed-TB study. The Lancet Infectious Diseases (2024).
2. Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis. The Lancet Child & Adolescent Health (2023).
3. Machine learning to predict bacteriologic confirmation of Mycobacterium tuberculosis in infants and very young children. PLOS Digital Health (2023).